Post My Press Release

Free Press Release Distribution

Category: Genomics Market (Page 1 of 3)

Protein Assays Market is Expecting Huge Revenue Growth by 2022

The increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for proteomics research are the major factors driving the growth of this market. In this report, the global protein assays market is segmented based on type, product, technology, application, end user, and region.

Based on type, the protein assays market is segmented into dye-binding assays, copper-ion-based assays, test strip-based assays, and other protein assays. On the basis of product, the protein assays market is segmented into reagents, kits, and instruments & accessories. In 2017, the reagents segment is expected to account for the largest share of the market. This growth can be attributed to the quick and ready-to-use modifications and the requirement of repeat purchase of reagents.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93720547

On the basis of technology, the protein assays market is segmented into absorbance-based protein assays, colorimetric protein assays, and fluorescence-based protein assays. Based on application, the protein assays market is segmented into disease diagnosis, drug discovery & development, and other applications. The drug discovery & development segment is expected to account for the largest market share in 2017. The increase in the R&D expenditure in the life science industry is a key market driver for this segment.

Based on end user, the protein assays market is segmented into pharmaceutical & biotechnology companies, clinical laboratories, hospitals, academic research institutes, and other end users. In 2017, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. This growth can be attributed to the increasing drug development in the life science industry.

On the basis of region, the global protein assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. The growth in this region is primarily driven by the increasing pharmaceutical and biotechnology R&D expenditure and availability of government funding for life sciences research.

Some of the major players operating in the protein assays market are Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).

Read More@ 
https://www.marketsandmarkets.com/PressReleases/protein-assay.asp

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Global Antibiotic Resistance Markets, 2019-2023 – Technavio

Technavio has published a new market research report on the global antimicrobial therapeutics market from 2019-2023. 

Antiviral application segment will garner the highest share.

Antiviral was the largest application segment of the global antimicrobial therapeutics market in 2018 and is expected to grow faster than the overall market during the forecast period. The rising incidence of viral infections such as influenza, hepatitis, and HIV/AIDS is driving the growth of the antiviral segment in the antimicrobial therapeutics market. Hepatitis C is one of the major blood-borne infections across the world. Similarly, HIV is one of the most common causes of deaths across the world, especially in the US. Therefore, high prevalence of these diseases will stimulate the growth of the antiviral application segment during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190621005078/en/

Increased disease diagnostic modalities

Although antimicrobials have had considerable progress over the last few years, many people are still being diagnosed with deadly diseases such as HBV and HIV. Effective treatment lies in early diagnosis, which depends on improved access to high-quality diagnostics to diagnose infection and monitor treatment. Moreover, the healthcare sector has been evolving and the centers have been equipped with sophisticated diagnostic modalities and POC diagnostic tests over the past five years. Many companies are focusing on developing PoC products, which can significantly reduce the time for diagnosis and ensure high patient compliance. Such increased disease diagnostic modalities are expected to fuel the growth of the global antimicrobial therapeutics market size during the forecast period.

“The antiviral segment of the global antimicrobial therapeutics market is expected to witness an accelerated growth momentum during the forecast period. One of the key factors driving growth includes the robust pipeline of antibacterial and antiviral drugs. As the usage of antibacterial and the antiviral drugs is increasing, the development of the pipeline drugs will positively impact the growth of this segment during the forecast period,” says a senior research analyst at Technavio.

Speak to Research Expert @ https://www.technavio.com/talk-to-us?report=Antimicrobial%20Therapeutics%20Market%20by%20Application%20and%20Geography%20-%20Global%20Forecast%20and%20Analysis%202019-2023&type=customization

Antimicrobial therapeutics to witness fastest adoption in Asia.

APAC is expected to be the fastest growing region of the global antimicrobial therapeutics market during the forecast period. The growth of the market in Asia can be attributed to the rising incidence of microbial diseases, and the presence of NIPs in countries such as Japan, India, and China, which aim at expanding the reach of vaccines. Moreover, non-government agencies and vaccine manufacturers across the world, are voluntarily helping patients to eradicate deadly diseases. Furthermore, the approval of new drugs is also expected to boost the antimicrobial therapeutics market growth in Asia.

Few Major Vendors in the global antimicrobial therapeutics market are:

  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co Inc.
  • Pfizer Inc.
  • Sanofi

Browse Industries Reports @ Pharmaceuticals, Biotechnology & Life Sciences

About Technavio

Technavio is a leading global technology research and advisory company. It provides detailed market research reports that provide clients with actionable insights to help them identify market opportunities and design effective strategies to optimize their market position.

With over 500 specialized analysts, Technavio boasts of an extensive report library comprising of over 10,000 reports, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than a hundred Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets. Technavio helps companies to assess their competitive position within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research 
Jesse Maida 
Media & Marketing Executive 
US: +1 844 364 1100 
UK: +44 203 893 3200 
www.technavio.com

Electronic Logging Device (ELD) Market Size to hit USD 2.53 billion by 2023

Technavio has published a new market research report on the global electronic logging devices (ELDs) market from 2019-2023.

Global electronic logging devices (ELDs) market: Integration of mobile devices with ELD

The adoption of smart devices, such as smartphones, has increased drastically over the last few years and is constantly increasing in developing regions such as APAC, MEA, and South America. The rising penetration of smartphones is increasing the demand for smartphone-based ELDs as they allow drivers to easily access their driving data. Such systems consist of an ELD app, which informs drivers about the time spent working outside the vehicle and behind the wheel. Therefore, the benefits associated with smartphone-based ELDs have encouraged various vendors to offer such solutions. This, in turn, will have a positive impact on the electronic logging devices (ELDs) market growth during the forecast period.

“Apart from the integration of mobile devices with ELD, other factors such as the growing number of electric vehicles (EVs), and the rising use of analytics with ELDs will have a significant impact on the growth of the electronic logging devices (ELDs) market size during the forecast period,” says a senior analyst at Technavio.

Speak to Research Expert @ https://www.technavio.com/talk-to-us?report=Electronic%20Logging%20Devices%20(ELDs)%20Market%202019-2023%20by%20Component%20and%20Geography%20-%20Global%20Forecast%202019-2023&type=customization&utm_source=pressrelease

Global electronic logging devices (ELDs) market: Segmentation analysis

This market research report segments the global electronic logging devices (ELDS) market by component (telematics unit, engine module, and external display), and geographic regions (Europe, North America, APAC, MEA, and South America).

The European region led the electronic logging devices (ELDs) market in 2018, followed by North America, APAC, MEA, and South America respectively. The region is witnessing an increase in manufacturing activities, which has resulted in a corresponding need to improve the logistics infrastructure to facilitate efficient delivery of goods. ELDs help enterprises in the logistics industry to automatically record effective drive-time of the vehicle, for more accurate and easier HOS recording and reporting.

Global electronic logging devices (ELDs) market: Use of ELDs to enhance the quality of driving

ELDs can monitor the driving habits of drivers. They can detect sudden stops, sharp turns, or quick accelerations and communicate the data to fleet managers on their dashboards. This allows managers to provide feedback to drivers about their driving habits. ELDs allow drivers to focus on driving and delivering products without worrying about paperwork as time is tracked automatically by ELDs. Therefore, the use of ELDs can enhance the quality of driving , which is expected to increase the demand for ELDs during the forecast period.

Few Major Vendors in the Dual-Axis Solar Tracker Market are:

  • Donlen Corp.
  • Geotab Inc.
  • Omnitracs LLC
  • Teletrac Navman US Ltd.
  • Trimble Inc.

Browse Industries Reports @ Auto Components

About Technavio

Technaviois a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida 
Media & Marketing Executive 
US: +1 844 364 1100 
UK: +44 203 893 3200 
www.technavio.com

Genomics Market Growth Opportunities, Industry Analysis And Forecast 2025 : Grand View Research Inc.

San Francisco, 12 August 2019: The Report Genomics Market Size, Share & Trends Analysis Report By Application And Technology (Pathway Analysis, Functional Genomics), By Deliverables (Instruments, Consumables, Services), By End Use, And Segment Forecasts, 2019 – 2025

The global genomics market size is expected to reach USD 27.61 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.6% during the forecast period. The past decades have witnessed significant changes in disease management processes due to simultaneous advancements in genomics and personalized medicine. There has been a gradual growth in the usage of genomic studies in clinical practices, which is reflected by the growing trend of targeted therapies.

Results from genomic studies enable a better understanding of diseases and the underlying mechanisms for researchers, physicians, and consumers. This facilitates evidence-based decision-making, and hence, helps improve personalized treatment regime. In addition, technological advancements in data analysis tools have motivated healthcare community to create precision-based therapies from surplus, available DNA data.

Ability of the medical community to make use of the available genomic information in personalized medicine is anticipated to significantly impact the genomics market. Furthermore, plummeting cost of sequencing has enabled the whole genome sequencing at very less price. Scientists are combining the sequencing generated data with diagnostics which has proven its effectiveness in enhancing personalized treatment landscape.

The companies are involved in strategic alliances with global as well as local entities to boost their revenue generation and enhance their market share. For instance, in March 2017, Foundation Medicine collaborated with Bristol-Myers Squibb Company, as a result of which Bristol-Myers Squibb could deploy Foundation Medicine’s molecular information solutions and comprehensive genomic profiling for identification of predictive biomarkers, such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB), to accelerate its immunotherapy clinical trials.

NGS-based services held a major market share in the services segment due to its rapid adoption of whole genome sequencing and application of sequence databases for disease screening and prognosis. The demand would remain strong with the expansion of the customer base from limited to academic and research centers to CROs, biotech and pharma players. As patients are focusing on their health, Direct-To-Consumer (DTC) laboratory testing is increasingly being employed. DTC genetic tests enable consumers to access information about their genetics without necessarily including healthcare professionals in the process.

Access Research Report of Genomics Market @ www.grandviewresearch.com/industry-analysis/genomics-market

Further key findings from the report suggest:

  • High demand in terms of volume coupled with the high cost of specific reagents contribute to substantial revenue share. Companies are embracing the trend of offering varied reagents that simplify workflow process
  • Use of predictive biomarkers for diagnosis and monitoring take cancer eradication a step further. Moreover, organizations and programs such as the National Biomarker Development Alliance (NBDA) are actively participating in development of novel biomarkers for cancer diagnosis
  • Growing interest of pharmaceutical and biotechnology companies in genomics is expected to drive growth of the genomics market in the forthcoming years
  • Asia Pacific is anticipated to display the maximum potential and an become an emerging market for genomics. It is anticipated to register the fastest CAGR of 10.4% over the forecast period
  • Major players include BGI; Agilent Technologies; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc; Foundation Medicine, Inc, 23andMe, Inc, Danaher, Illumina, Inc; Pacific Biosciences; Oxford Nanopore Technologies.; F. Hoffmann-La Roche Ltd., and Myriad Genetics, Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global genomics market on the basis of application and technology, deliverable, end use, and region:

Genomics Application and Technology Outlook (Revenue, USD Million, 2014 – 2025)

  • Functional Genomics
    • Real-time PCR
    • Transfection
    • SNP Analysis
    • Mutational Analysis
    • Microarray Analysis
    • RNA Interference
  • Pathway Analysis
    • Microarray Analysis
    • Bead-based Analysis
    • Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
    • Real-time PCR
  • Biomarker Discovery
    • DNA Sequencing
    • Microarray Analysis
    • Real-time PCR
    • Mass Spectrometry
    • Statistical Analysis
    • Bioinformatics
  • Epigenetics
    • Bisulfite Sequencing
    • Microarray Analysis
    • Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
    • Methylated DNA Immunoprecipitation (MeDIP)
    • High Resolution Melt (HRM)
    • Chromatin Accessibility Assays
  • Others

Genomics Deliverables Outlook (Revenue, USD Million, 2014 – 2025)

  • Products
    • Instruments/Systems/Software
    • Consumables & Reagents
  • Services
    • NGS-based Services
    • Core Genomics Services
    • Biomarket Translation Services
    • Computational Services
    • Others

Genomics End Use Outlook (Revenue, USD Million, 2014 – 2025)

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Academic and Government Institutes
  • Clinical Research
  • Other End Users

Genomics Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Access Press Release of Genomics Market @ www.grandviewresearch.com/press-release/genomics-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

NGS Sample Preparation Market worth $2.7 billion by 2024

Factors such as advancements in NGS platforms, reduced cost of sequencing, and improving reimbursement scenario for NGS-based diagnostic tests are driving the growth of this market. However, while the costs involved in NGS have reduced to some extent, they have not reached a level where broad adoption across developing markets can be achieved. This is a key restraint for market growth.

The reagents, and consumables segment to dominate the overall NGS sample preparation market in 2018

Based on product, the NGS sample preparation market is segmented into workstations and reagents & consumables. The reagents & consumables segment was further subsegmented into library preparation, target enrichment, and quality control, on the basis of workflow.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69735098

In 2018, the reagents and consumables segment accounted for the largest share of the NGS sample preparation market. Factors such as the decreasing cost of sequencing; availability of cost-efficient and advanced NGS platforms; increasing applications of NGS in different fields such as drug and biomarker discovery, diagnostics, agro-genomics, and animal research; increasing research activity involving sequencing; and the availability of research grants (that are driving the adoption of NGS) have all contributed to the growth of this market.

The diagnostics segment is estimated to grow at the highest CAGR during the forecast period

Based on application, the NGS sample preparation market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications. The diagnostics segment is estimated to grow at the highest rate during the study period owing to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT.

North America dominated the market in 2018

North America is the dominant revenue-generating region in the global NGS sample preparation market. The large share of this regional segment can mainly be attributed to the favorable initiatives by government and private bodies for the development and adoption of NGS technologies, wide adoption of NGS diagnostics in the region, increasing number of NGS-based research & clinical applications in the region, growing research on cancer, rising awareness of NGS services, and the presence of leading NGS service providers.

Some of the prominent players in the NGS sample preparation market include Illumina Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), Beckman Coulter (a subsidiary of Danaher), and Becton, Dickinson and Company (BD) (US) among others.

Read More@ 
https://www.marketsandmarkets.com/PressReleases/ngs-sample-preparation.asp

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Cell Isolation Market worth $13.0 billion by 2024

The study involved four major activities to estimate the current market size for the global cell isolation market. Exhaustive secondary research was done to collect information on the market and its different subsegments. 

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

The study involved four major activities to estimate the current market size for the global cell isolation market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

On the basis of type, the cell isolation market is segmented into consumables and instruments. In 2018, the consumables segment accounted for a larger share of the cell isolation market. The dominant share of this segment can be attributed to the increasing investments by companies to develop technologically advanced products and the repetitive use of consumables.

On the basis of technique, the cell isolation market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. The centrifugation-based cell isolation segment is expected to account for the largest market share in 2018. This technique is used on a large scale by biotech and biopharmaceutical companies and its cost-effectiveness in both small-scale and large-scale operations is a major reason its dominant share.

Based on product, the cell isolation market is segmented into consumables and instruments. During the forecast period, the consumables segment is estimated to register a higher growth rate. The increasing investments by companies to develop advanced products and the rising government initiatives for enhancing cell-based research are driving the growth of this segment.

North America is one of the major revenue-generating regions in the global cell isolation market. The large share of the North American market is attributed to increasing government support for cancer and stem cell research, the expanding biotechnology and biopharmaceutical industries and the increasing prevalence of chronic and infectious diseases in which cell isolation is required for diagnosis and treatment. This will result in, increase in demand for cell isolation products.

Prominent players in the cell isolation market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KgaA (Germany), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (US), Thermo Fisher Scientific (US), and Bio-Rad Laboratories Inc. (US).

Read More@ 
https://www.marketsandmarkets.com/PressReleases/cell-isolation.asp

The key strategies followed by most companies in the cell isolation market are product launches, expansions, agreements, and acquisitions to achieve growth in the cell isolation market. The product launches accounted for the largest share of the overall growth strategies adopted from 2015 to 2018.

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Protein Assays Market worth 2.41 Billion USD by 2022 | an Exclusive Report by MarketsandMarkets

Protein assays are used in life science research to determine the total protein concentration. Estimation of protein concentration is necessary for protein purification, electrophoresis, cell biology, molecular biology, and research applications. The market is witnessing high growth due to factors such as increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for Proteomics research.

Target Audience for this Report:
# Protein assay manufacturers and vendors
# Distributors of protein assays
# Various research and consulting companies
# Associations related to pharmaceutical and biotechnological research

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93720547

Value Addition for the Buyer:

This report aims to provide insights into the global protein assays market. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Based on end user, the protein assays market is segmented into pharmaceutical & biotechnology companies, clinical laboratories, hospitals, academic research institutes, and other end users. In 2017, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. This growth can be attributed to the increasing drug development in the life science industry.

On the basis of region, the global protein assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. The growth in this region is primarily driven by the increasing pharmaceutical and biotechnology R&D expenditure and availability of government funding for life sciences research.

Read More@ 
https://www.marketsandmarkets.com/Market-Reports/protein-assay-market-93720547.html

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Molecular Biology Enzymes and Kits & Reagents Market worth 13.60 Billion USD by 2022

The key factors driving the growth of Molecular Biology Enzymes Market include increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases and genetic disorders. However, the privacy concerns related to genetic information and limited reimbursements for genetic testing may hinder the growth of this market to a certain extent.

By product, the kits & reagents segment to account for the largest share of the market in 2017

On the basis of product, the molecular biology enzymes and kits & reagents market is segmented into enzymes and kits & reagents. In 2017, kits & reagents segment is expected to account for the largest share of the global market. The large share of this segment can be primarily attributed to the requirement of repeat purchase of these single-use products and increasing drug research in the pharmaceutical industry. The enzymes market is further subsegmented into polymerases, ligases, restriction endonucleases, reverse transcriptases, phosphatases, proteases & proteinases, and other enzymes. In 2017, the polymerases enzymes segment is expected to account for the largest share of the enzymes market.

By application, the polymerase chain reaction (PCR) segment to hold the largest market share in 2017

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164131709

Based on application, the market is segmented into polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection). The polymerase chain reaction (PCR) segment is expected to command the largest share of the molecular biology enzymes and kits & reagents market in 2017. The large share of this segment can be attributed to the low cost of PCR equipment, use of PCR equipment by the majority of the end users, and increasing use of PCR for molecular diagnostic assays in hospitals and clinics.

By end user, academic & research institutes to hold the largest market share in 2017

Based on end user, the market is segmented into academic & research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies, and other end users (contract research organizations (CROs), food & beverage companies, and forensic agencies). The academic & research institutes segment is expected to command the largest share of the molecular biology enzymes and kits & reagents market in 2017. The large share of this segment can be attributed to the increasing research activities backed by funding from government and private organizations.

North America to dominate the market in 2017

In 2017, North America is expected to account for the largest share of the molecular biology enzymes and kits & reagents market, followed by Europe, Asia Pacific (APAC), and the Rest of the World (Latin America and the Middle East & Africa). Factors such as increasing research funding for genomics research, rising number of pharmaceutical and biotechnology companies, favorable reimbursement scenario for molecular diagnostics, and growing prevalence of target indications are contributing to the large share of North America.

Read More@ 
https://www.marketsandmarkets.com/PressReleases/molecular-biology-enzymes-kits-reagents.asp

The molecular biology enzymes and kits & reagents market in several APAC countries, particularly, China, Japan, and India, are expected to witness high growth during the forecast period. This can be attributed to the increasing government interest in biomedical and biotechnology industries, outsourcing of clinical research activities to China, involvement of industry players in the Japanese market, growing pharmaceutical industry in India backed by government initiatives to drive market growth, and initiatives by non-profit organizations.

The key players in the global molecular biology enzymes and kits & reagents market are Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US).

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Page 1 of 3

Powered by WordPress & Theme by Anders Norén